Zhang YC, Wang JN, Ma SY, Cai J, et al. Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma. Br J Haematol 2021 Oct 7. doi: 10.1111/bjh.17849.
PMID: 34618912